FDA
-
-
-
-
-
-
-
Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
-
-
-
-
-
-
-
Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2020
-
-
-
-
-
-
-
Spectrum Pharmaceuticals Appoints Dr. Jeffrey Vacirca to its Board of Directors
322,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

